Pipeline
In partnership with world-class academic labs, we are developing a pipeline of small molecules and targeted protein degraders.
We have had until now 100% of success in finding novel hits.
In some cases, we are the first team to discover a ligand for a target.
Do you have a drug development project that you would like to co-develop with us? Contact us and let's discuss if we can accelerate together.
Do you have a drug development project that you would like to co-develop with us? Contact us and let's discuss if we can accelerate together.
Indication
In silico
In vitro
In vivo
Year
Oncology
Oncology
In vivo validation
Ongoing
2021
Fragile-X
Fragile-X
In vivo validation
Ongoing
2022
Oncology
Oncology
In vitro validation
Completed
2022
Channelopathies
Channelopathies
In vitro validation
Completed
2022
Oncology
Oncology
In vitro validation
Completed
2022
Oncology
Oncology
In vitro validation
Ongoing
2022
Oncology
Oncology
In vitro validation
Ongoing
2023
Rare Disease
Rare Disease
In silico discovery
Completed
2023
Oncology-Degrader
Oncology-Degrader
In silico discovery
Completed
2023